R&D

Showing 15 posts of 140 posts found.

Alderley park image

AstraZeneca sells Alderley Park

March 13, 2014
Research and Development, Sales and Marketing AstraZeneca, Manchester, Osborne, R&D, alderley park, research

AstraZeneca has sold its former R&D site in Cheshire to a public-private consortium for an undisclosed sum, and expects the …

Forest labs image

Forest cuts jobs in restructure

December 4, 2013
Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts

Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …

research image

Report: ‘R&D isn’t paying’

December 3, 2013
Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters

On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …

Eisai image

Eisai reorganises R&D

December 2, 2013
Research and Development, Sales and Marketing Eisai, R&D, cfu, epcs, pcu, reorganisation

Tokyo-based Eisai is to axe 130 jobs in Europe and the US as part of an attempt to shake up …

Department of health

Coalition launches rare disease strategy

November 22, 2013
Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease

The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …

amgen image

Amgen to open Chinese R&D centre

September 26, 2013
Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

NICE image

NICE queries pharma R&D costs

September 5, 2013
Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D

NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …

syntaxin image

Ipsen buys Syntaxin

July 16, 2013
Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

Sanofi image

Sanofi makes Curie cancer deal

June 20, 2013
Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie

Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …

John LaMattina: India’s solution to drug costs

May 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013
Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

Pharma R&D ‘untenable’

April 25, 2013
Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …

Latest content